Hyperthermic intrapleural chemotherapy: an update

The safety and efficacy of hyperthermic intrathoracic chemotherapy (HITHOC) as an adjunct to cytoreductive surgery (CRS) in pleural malignancies has been well demonstrated. This is most often described in cases of mesothelioma, thymoma, or other secondary pleural metastases. The utilization of a dir...

Descripción completa

Detalles Bibliográficos
Autores principales: Campany, Megan E., Reck dos Santos, Pedro A., Donato, Britton B., Alwardt, Cory M., Ernani, Vinicius, D’Cunha, Jonathan, Beamer, Staci E.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: AME Publishing Company 2023
Materias:
Review Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10586986/
https://www.ncbi.nlm.nih.gov/pubmed/37868886
http://dx.doi.org/10.21037/jtd-23-454

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10586986/
https://www.ncbi.nlm.nih.gov/pubmed/37868886
http://dx.doi.org/10.21037/jtd-23-454

Ejemplares similares